Drug Database
Back to search

Belgium· BE-AMP-SAM419684-00

Aminophylline Sterop 50 mg/ml

A aminophylline product containing aminophylline, registered in Belgium by Laboratoires Sterop. The same ATC class is registered in 11 of our 19 countries.

ATC R03DA05

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedAminophylline Sterop 50 mg/mlATCR03DA05REGISTER NO.BE-AMP-SAM419684-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about aminophyllineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Aminophylline is registered in 11 of 19 countries.

Countries holding a registration under ATC R03DA05 (aminophylline), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose
Search aminophylline products by name

Aminophylline · ATC R03DA05

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Ireland
  • Japan
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Aminophylline
Manufacturer
Laboratoires Sterop
Country
Belgium (BE)
ATC code
R03DA05
ATC class
Aminophylline
Defined daily dose
0.6 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    0389676
  • be_apb
    1845676

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

323 interactions on record for aminophylline.

Graded by severity as the source publishes them — 34 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check aminophylline against other medicinesHow interaction checks work

Aminophylline · interactions on record

323 records

  • 34 severe
  • 174 moderate
  • 38 minor
  • 76 info

Most severe, free to view

  • MexiletineC01BB02severe
  • RiociguatC02KX05severe
  • PindololC07AA03severe
  • PropranololC07AA05severe

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Aminophylline in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All aminophylline products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Bulgaria · Софафилин
  • Czechia · Syntophyllin
  • Finland · Aminocont
  • France · Aminophylline Renaudin
  • United Kingdom (Northern Ireland) · Aminophylline N.A., Phyllocontin
  • Greece · Aminophylline Cooper, Αμινοφυλλινη Demo
  • Croatia · Brolyfin
  • Hungary · Diaphyllin Venosum
  • Ireland · Aminophylline Hydrate Mercury Pharmaceuticals (Ireland) Ltd, Phyllocontin
  • Italy · Aminofillina Galenica Senese, Aminofillina Monico
  • Lithuania · Aminophylline Sopharma Ad, Eufilinas
  • Latvia · Sophafyllin
  • Portugal · Aminofilina Labesfal, Filotempo
  • Romania · Aminofilină Arena, Aminofilina Bioeel
  • Sweden · Teofyllamin
  • Slovakia · Syntophyllin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c170f148-3a0c-4355-b411-17e1af530cfa
GET /v1/drugs/c170f148-3a0c-4355-b411-17e1af530cfa?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Aminophylline Sterop 50 mg/ml",
  "name_fr": "Aminophylline Sterop 50 mg/ml",
  "name_nl": "Aminophylline Sterop 50 mg/ml",
  "amp_code": "SAM419684-00",
  "strengths": [
    "50.0000"
  ],
  "pack_count": 3,
  "substances": [
    "Aminophylline"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Aminophylline",
  "authorisation_numbers": [
    "BE419684"
  ]
}
API referenceMCP serverPlans

See everything about aminophylline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console